The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures?

NCT ID: NCT02606058

Last Updated: 2020-11-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1637 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-09-30

Study Completion Date

2020-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To establish if placental transfusion, using deferred cord clamping for 60 seconds or more while holding the baby at or below the level of the placenta, will improve survival without disability compared with standard early cord clamping in preterm babies less than 30 weeks of gestation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Most preterm babies have the umbilical cord clamped within 10 seconds of birth. Placental transfusion is a simple way of giving the baby extra blood at birth by delaying the clamping of the umbilical cord by 60 seconds or more. There is promising evidence from randomised trials that placental transfusion in babies less than 37 weeks of pregnancy may improve their blood pressure, reduce the number of blood transfusions needed and decrease bleeding into the brain, bowel disease and infection. However, we not know if babies born before 30 weeks of pregnancy benefit or if placental transfusion increases or decreases death or childhood disability. Despite this uncertainty more doctors are recommending that all very preterm babies are given a placental transfusion at birth. It is important to find out if placental transfusion does more good than harm, before it becomes even more widely used.

The Australian Placental Transfusion Study will enrol at least 1600 women who will give birth to babies born less than 30 weeks of gestation. These participants will be randomly assigned to either standard treatment where the umbilical cord is clamped within 10 seconds of birth or a second method where the umbilical cord will be clamped after waiting for 60 seconds or more at birth while the baby is being held below the level of the placenta. The main research question is whether placental transfusion reduces death and disability when the baby is discharged from hospital and into childhood.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preterm Birth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early cord clamping (Control Arm)

Immediate cord clamping (\< 10 seconds after birth). The cord is clamped 6 cm from the umbilicus within ten seconds of delivery of the baby.

Group Type NO_INTERVENTION

No interventions assigned to this group

Deferred cord clamping

Deferred cord clamping. Investigator/Research personnel holds the baby as low as possible below the level of the introitus or placenta for 60 seconds and not to exceed 80 seconds, then clamps the cord about 6 cm from the umbilicus.

Group Type EXPERIMENTAL

Deferred cord clamping

Intervention Type PROCEDURE

Deferred cord clamping (for 60 seconds or more with the baby held below or at the level of the placenta)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Deferred cord clamping

Deferred cord clamping (for 60 seconds or more with the baby held below or at the level of the placenta)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Women who have a reasonable chance of delivering less than 30 weeks of gestation. Informed consent has been received from the parent or guardian.

Exclusion Criteria

No indication or contraindication to placental transfusion, in the view of mother or baby.
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Health and Medical Research Council, Australia

OTHER

Sponsor Role collaborator

Baylor College of Medicine

OTHER

Sponsor Role collaborator

University of Sydney

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

William T Mordi, MD

Role: PRINCIPAL_INVESTIGATOR

University of Sydney

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Baylor College of Medicine

Houston, Texas, United States

Site Status

University of Vermont Medical Centre

Burlington, Vermont, United States

Site Status

Canberra Hospital

Canberra, Australian Capital Territory, Australia

Site Status

John Hunter Hospital

Newcastle, New South Wales, Australia

Site Status

Liverpool Hospital

Sydney, New South Wales, Australia

Site Status

Royal Prince Alfred Hospital

Sydney, New South Wales, Australia

Site Status

Royal North Shore Hospital

Sydney, New South Wales, Australia

Site Status

Royal Hospital for Women

Sydney, New South Wales, Australia

Site Status

Nepean Hospital

Sydney, New South Wales, Australia

Site Status

Mater Mother's Hospital

Brisbane, Queensland, Australia

Site Status

Royal Brisbane and Women's Hospital

Brisbane, Queensland, Australia

Site Status

Townsville Hospital

Townsville, Queensland, Australia

Site Status

Flinders Medical Centre

Adelaide, South Australia, Australia

Site Status

Monash Medical Centre

Melbourne, Victoria, Australia

Site Status

Mercy Hospital for Women

Melbourne, Victoria, Australia

Site Status

King Edward Memorial Hospital

Perth, Western Australia, Australia

Site Status

IWK Health Center

Halifax, Nova Scotia, Canada

Site Status

Hôpital Antoine-Béclère

Clamart, , France

Site Status

Auckland Hospital

Auckland, , New Zealand

Site Status

Christchurch Hospital

Christchurch, , New Zealand

Site Status

Dunedin Hospital

Dunedin, , New Zealand

Site Status

Waikato Hospital

Hamilton, , New Zealand

Site Status

Wellington Hospital

Wellington, , New Zealand

Site Status

Aga Khan University Hospital

Karachi, , Pakistan

Site Status

Royal Jubilee Maternity Hospital

Belfast, Northern Ireland, United Kingdom

Site Status

Craigavon Area Hospital

Craigavon, Northern Ireland, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Canada France New Zealand Pakistan United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ACTRN12610000633088

Identifier Type: REGISTRY

Identifier Source: secondary_id

H-34236

Identifier Type: -

Identifier Source: org_study_id